Drugs and Cosmetics Act and Schedule ‘Y’ Mr. NAGENDRAPPA. M. H Assistant Professor ICRI, Bangalore OBJECTIVES OF D & C ACT 1940  The Drugs and Cosmetics Act 1940…

Slide 1Improving FDAs approach to new drug approval and post-marketing surveillance Jerry Avorn, M.D. Professor of Medicine, Harvard Medical School Chief, Division of Pharmacoepidemiology…

Slide 1Medical Model VERSUSKinergetics Slide 2 PRESCRIPTION DRUGS The problem is, prescription drugs don't treat diseases; they merely cover the symptoms. U.S. physicians…

Slide 1Health Resource Center: Weekend Coordinator Orientation Tuesday, 12 October, 2009 Slide 2 General Comments Your role: you and another weekend coordinator will be in…

Slide 1Gold Standards Framework Dr Mohammed Javid Slide 2 Aims Deaths – Why, where, how End Of Life Care – EoLC, ACP, PPC, PPD, GSF, LCP Gold Standards Framework –…

Slide 1Improving end of life care Sue Cole, Staff Tutor Chris Kubiak, Lecturer The Open University Slide 2 Introduction Death and dying: an educational approach to improving…

1. AN EDUCATORS GUIDE ADHD 2. WHAT WE KNOW • According to the Centers for Disease Control, in 2013, 8.4% of children aged 3-17 have been diagnosed with Attention Deficit…

1. Total 1 million microarrays available ncbi.nlm.nih.gov www.ebi.ac.uk 2. Type 2 Diabetes Mellitus• Affects 20 million in US, 170 million world-wide• Leading cause of…

1. The Spell of Morpheus …so quickly take me by the hand a stranger in a stranger land. I know the secrets of your yearnings so don’t pretend that I can’t see. Come…

Drug Development, EMA, Nice & NHS England: how treatments are developed and licensed David Baker Why Does it take so Long to get Drugs Available? Why Donât Neurologists…